Discover our latest insights. 

For a very long time, the only option for breast cancer treatment was a radical mastectomy. Treatment slowly began to evolve in the 1960s with hormone therapy, radiation, and chemotherapy being adopted into clinical practice. But today, treatment options are evolving much more rapidly.

Cardiovascular diseases, including heart attack and stroke, cause 1 in 3 deaths in women each year¹. Some symptoms that women commonly experience during a heart attack are more subtle than the “classic” male symptoms. As a result, many women may not realize they are having a cardiovascular emergency and fail to seek treatment. Here, PHM share valuable information about heart attack and strokes in women, including new tools that are available for managing your heart health, along with symptoms, prevention, and risk management.

The drugs, Wegovy® and Ozempic® have been in the news and trending on social media due to their unprecedented success in helping people lose large amounts of weight. Our experts at PHM answer some common questions about the recently FDA approved drug, Wegovy.

Leqembi® (lecanemab) was approved to treat Alzheimer’s disease in January, 2023 under the FDA’s Accelerated Approval process for diseases with an unmet need for treatment.1 The manufacturers, Eisai pharmaceuticals, plan to submit data for full FDA approval by the end of March 2023.

Here, we answer some common questions about Leqembi and summarize what is known about its safety and effectiveness. Patients and their families should speak with their physician and weigh the potential benefits and risks before deciding whether to seek treatment with Leqembi.

Many people have experienced colds or flu-like illnesses already this winter. Experts are monitoring the levels and continued spread of these viruses, including flu, COVID-19, and RSV. This article will answer common …

As expected in the winter months, the flu virus spreads throughout our communities. Small children, the elderly, and immune compromised people are at higher risk for complications or serious illness from the …